Teriparatide treatment shows faster healing than sacroplasty for postmenopausal women with sacral insufficiency fracture
10.1016/j.afos.2023.02.001
- Author:
Yao-Chun YANG
1
;
Min-Hong HSIEH
;
Jui-Teng CHIEN
;
Keng-Chang LIU
;
Chang-Chen YANG
Author Information
1. National Taiwan University, School of Medicine, Taiwan
- Publication Type:Original article
- From:Osteoporosis and Sarcopenia
2023;9(1):27-31
- CountryRepublic of Korea
- Language:English
-
Abstract:
Objectives:Sacral insufficiency fracture (SIF) is not an uncommon osteoporosis fracture among the elderly. Aside from traditional treatments, sacroplasty and teriparatide (TPTD) injection have been introduced. This report aims to compare the effects of sacroplasty and teriparatide on clinical outcomes of SIF.
Methods:Thirty-one elderly patients with SIF were enrolled in this retrospective observational study. Four male patients were excluded. Fourteen patients who received TPTD for 6 months were classified into the TPTD group (TT), and 13 who underwent sacroplasty were classified into the sacroplasty group (SS). All patients in both groups were instructed to take calcium and vitamin D supplements daily. Their symptoms and signs, visual analog score (VAS), Oswestry disability index (ODI), and radiographic studies were retrospectively reviewed.
Results:The TT group showed significantly lower VAS than SS group after 3 (P < 0.001) and 6 months of treatment (P < 0.001). The TT group also has significant lower ODI than SS group after 1 (P = 0.010), 3 (P = 0.005) and 6 months (P < 0.001) of treatment. Upon generalized estimating equations (GEE) analysis, the TT group showed significantly more reduction in both VAS and ODI compared to the SS group at 1 month (P = 0.022, P = 0.001), 3 months (P < 0.001, P < 0.001), and 6 months (P < 0.001, P < 0.001) post-treatment.
Conclusions:Postmenoposal woman with SIF who received TPTD healed better than those who underwent sacroplasty after 1 month treatment.
